126 filings
8-K
MREO
Mereo Biopharma Group Plc
15 Apr 24
Entry into a Material Definitive Agreement
7:30am
8-K
MREO
Mereo Biopharma Group Plc
27 Mar 24
Mereo BioPharma Reports Full Year 2023 Financial Results and Provides Corporate Update
4:08pm
8-K
MREO
Mereo Biopharma Group Plc
8 Jan 24
Mereo BioPharma Provides Update on Pipeline Progress and Corporate Developments
7:08am
6-K
MREO
Mereo Biopharma Group Plc
18 Dec 23
Current report (foreign)
4:10pm
6-K
MREO
Mereo Biopharma Group Plc
29 Nov 23
Current report (foreign)
4:15pm
6-K
ajkdo4wb8x sdq
16 Nov 23
Current report (foreign)
7:01am
6-K
hle2lz31g820hnkz
23 Oct 23
Mereo BioPharma Reports on Recent Program Developments and Provides Financial Update
4:08pm
6-K
00d1p l4bxl1q
17 Oct 23
Current report (foreign)
7:01am
6-K
oy8840ca4w0jgc0
20 Sep 23
Current report (foreign)
4:03pm
6-K
hhdpxb5kfhbd
7 Sep 23
Current report (foreign)
7:37am
6-K
np4txymrvy9dk1ns5qj
6 Jul 23
Ultragenyx Announces First Patients Dosed in Phase 3 Program
8:05am
6-K
szif2p 3s1rqat8jo
30 Jun 23
Current report (foreign)
4:05pm
6-K
uj5upypmeh35zhj
7 Jun 23
Current report (foreign)
8:41am
6-K
e2z6to9jmk
5 Jun 23
Ultragenyx and Mereo BioPharma Announce Positive Data from the Ongoing Phase 2/3 Orbit
4:37pm
6-K
w4yo6dy
22 May 23
Current report (foreign)
4:15pm
6-K
l0roe5mxyno
8 May 23
Current report (foreign)
4:07pm
6-K
75gm3hugp2nc5svs
5 May 23
Mereo BioPharma Announces Listing Transfer to Nasdaq Capital Market
5:06pm
6-K
bkk6g5o1 pkr7
27 Apr 23
Current report (foreign)
4:15pm
6-K
4x30z4gj3xaqd1a
12 Apr 23
Current report (foreign)
4:01pm
6-K
epx5j1wpz 0mvr0obb
28 Mar 23
Mereo BioPharma Reports Full Year 2022 Financial Results and Recent Highlights
4:37pm